CW August 2006

category image Volume 15
Issue Number 8
August 2006
ISSN 10593802

Stimulating Killer Cell Activity Might Assist Breast Cancer Drug

Interleukin-21, which stimulates natural killer cells to secrete interferon gamma, may enhance the antitumor effect of Herceptin, the monoclonal antibody used to treat HER2-positive breast cancer.
Go to Previous Page
Go to Next Page

Source & Additional Reading

William E. Carson, III, online edition of Journal of immunology, July 1, 2006.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW August 2006

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login